Summary: Through June of this year, the cholesterol-lowering drug rosuvastatin (Crestor, AstraZeneca) was the most prescribed branded drug in the United States, and the arthritis drug adalimumab (Humira, Abbott Laboratories) was the best-selling branded drug, according to the latest data from research firm IMS Health,” Megan Brooks reported in Medscape Medical News. Also in the top sellers: Enbrel for arthritis, Abilify, the antipsychotic; Lantus Solostar, insulin; Sovaldi, for hepatitis C; and Advair Diskus for asthma.
